Company intelligence / Profile preview

Kraeber

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Kraeber is a leading independent German supplier and manufacturer of active pharmaceutical ingredients (APIs), intermediates, excipients, natural extracts and biological substances for the pharmaceutical industry. The company is GMP-certified and ISO 9001 certified. It supplies both synthetic molecules and biologics derived from animal or plant sources to pharma/biotech companies globally. Its products are used in pharmaceuticals as well as medical devices, diagnostics/lab reagents, cosmetics/nutraceuticals/food industries.

Therapeutic areas: Other
Modalities: Small moleculeBiologicProteinBlood and blood product
Industry: Contract Manufacturing Organization

Partnerships

Not publicly disclosed; works with global pharma/biotech/cosmetic/nutraceutical clients as an ingredient supplier/manufacturer

Beyond the preview

Go deeper on Kraeber.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kraeber.